p53 Protein Transduction Therapy: Successful Targeting and Inhibition of the Growth of the Bladder Cancer Cells
- 31 January 2006
- journal article
- Published by Elsevier in European Urology
- Vol. 49 (1) , 161-168
- https://doi.org/10.1016/j.eururo.2005.08.019
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 15 references indexed in Scilit:
- Comparison of Viral Vectors: Gene Transfer Efficiency and Tissue Specificity in a Bladder Cancer ModelJournal of Urology, 2003
- Protein Therapy: In Vivo Protein Transduction by Polyarginine (11R) PTD and Subcellular Targeting DeliveryCurrent Protein & Peptide Science, 2003
- Current understanding of the biology of advanced bladder cancerCancer, 2003
- Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivoGene Therapy, 2003
- Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancerUrology, 2002
- An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapiesCancer Gene Therapy, 2000
- Protein transduction: unrestricted delivery into all cells?Trends in Cell Biology, 2000
- LOSS OF ADENOVIRAL RECEPTOR EXPRESSION IN HUMAN BLADDER CANCER CELLS- A POTENTIAL IMPACT ON THE EFFICACY OF GENE THERAPYJournal of Urology, 1999
- Gene therapy - promises, problems and prospectsNature, 1997
- Adenoviral - P53 Gene Transfer to Orthotopic and Peritoneal Murine Bladder CancerJournal of Urology, 1996